AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,860 | +24.6% | 49,000 | 0.0% | 0.00% | +33.3% |
| Q2 2023 | $44,835 | +175.9% | 49,000 | +69.0% | 0.00% | +200.0% |
| Q1 2023 | $16,252 | -2.9% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $16,733 | +85.9% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $9,000 | -10.0% | 29,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |